Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-09-30
1999-07-13
McKane, Joseph K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548491, A61K 31405, C07D20912
Patent
active
059227524
ABSTRACT:
The present invention is new excitatory amino acid antagonists (herein referred to as compounds of formula (1)): below: ##STR1## These new antagonists are useful as NMDA (N-methyl-D-aspartate) antagonists.
REFERENCES:
patent: 5106847 (1992-04-01), Salituro et al.
patent: 5519048 (1996-05-01), Salituro et al.
patent: 5563157 (1996-10-01), Harrison et al.
Salitouro F.G. et al., Bioorganic & Medicinal Chem. Ltrs., vol. 1, No. 9, pp. 455-460, 1991.
Kemp John A., TiPS -Jan. 1993, vol. 14, No. 1, pp. 20-25.
Schelkun, R.M. et al, 33rd Nat's Organic Chemistry Symposium Bozeman, MT-Jun. 1993 Abstract, #b-73.
Thornber, Chemical Society Review, vol. 8, No. 4, 1979.
Baron Bruce M.
Gross Raymond S.
Harrison Boyd L.
Ferrell Michael W.
Hoechst Marion Roussell, Inc.
McKane Joseph K.
Stemerick David M.
LandOfFree
NMDA (n-methyl-d-aspartate) antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NMDA (n-methyl-d-aspartate) antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NMDA (n-methyl-d-aspartate) antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2276056